Mabion S.A.

Symbol: MAB.WA




Market price today

  • 4.7713

    P/E Ratio

  • 0.4648

    PEG Ratio

  • 258.60M

    MRK Cap

  • 0.00%

    DIV Yield

Mabion S.A. (MAB-WA) Stock Price & Analysis

Shares Outstanding


Gross Profit Margin


Operating Profit Margin


Net Profit Margin


Return on Assets


Return on Equity


Return on Capital Employed


Company general description and statistics

Sector: Healthcare
Industry: Biotechnology
CEO:Mr. Krzysztof Kaczmarczyk
Full-time employees:248
City:Konstantynów Lódzki
Address:ul. gen. Mariana Langiewicza 60

Mabion S.A., a biotechnology company, engages in the development of various biotech drugs based on monoclonal antibody technology in Poland. The company develops, produces, and sells medicines for the treatment of neoplastic, autoimmune, metabolic, and neurological diseases. Its products include MabionCD20 and MabionHER2. The company was founded in 2007 and is based in Konstantynów Lódzki, Poland.

General Outlook

In simple terms, Mabion S.A. has 16.162 M shares that people are buying and selling right now. When we look at how much money they make before expenses, they keep 0.749% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is 0.405%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of 0.393%. This tells us they're good at keeping money after all costs.

Return on Investments

The company's asset efficiency, represented by a robust 0.253% return, is a testament to Mabion S.A.'s adeptness in optimizing resource deployment. Mabion S.A.'s utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of 0.587%. Furthermore, the proficiency of Mabion S.A. in capital utilization is underscored by a remarkable 0.389% return on capital employed.

Stock Prices

Mabion S.A.'s stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $17.2, while its low point bottomed out at $16.96. This variance in figures offers investors a lucid insight into the roller-coaster ride that is Mabion S.A.'s stock market.

Liquidity Ratios

Analyzing MAB.WA liquidity ratios reveals its financial health of the firm. The current ratio of 148.51% gauges short-term asset coverage for liabilities. The quick ratio (138.37%) assesses immediate liquidity, while the cash ratio (109.31%) indicates cash reserves.

Current Ratio148.51%
Quick Ratio138.37%
Cash Ratio109.31%

Profitability Ratios

MAB.WA profitability indicators offer a lens into its earnings landscape. A pretax profit margin of 38.56% underscores its earnings before tax deductions. The effective tax rate stands at -5.30%, revealing its tax efficiency. The net income per EBT, 102.02%, and the EBT per EBIT, 95.30%, provide insights into its earnings hierarchy. Lastly, with an EBIT per revenue ratio of 40.46%, we grasp its operational profitability.

Pretax Profit Margin38.56%
Effective Tax Rate-5.30%
Net Income per EBT102.02%
EBT per EBIT95.30%
EBIT per Revenue40.46%

Operational Efficiency

Operational metrics shed light on its business agility. With an operating cycle of 1.49, it details the span from stock purchase to revenue. The 1 days it takes to settle debts showcases its creditor relations. Meanwhile, a 1 cash conversion cycle and 667.06% receivables turnover rate reflect its cash flow efficiency and credit management, respectively.

Days of Sales Outstanding138
Days of Inventory Outstanding76
Operating Cycle130.93
Days of Payables Outstanding44
Cash Conversion Cycle87
Receivables Turnover6.67
Payables Turnover8.37
Inventory Turnover4.79
Fixed Asset Turnover1.44
Asset Turnover0.64

Cash Flow Ratios

Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, 3.85, and free cash flow per share, 2.08, depict cash generation on a per-share basis. The cash per share value, 5.17, showcases liquidity position. Lastly, the operating cash flow sales ratio, 0.42, offers insight into cash flow relative to sales.

Operating Cash Flow per Share3.85
Free Cash Flow per Share2.08
Cash per Share5.17
Operating Cash Flow Sales Ratio0.42
Free Cash Flow to Operating Cash Flow Ratio0.54
Cash Flow Coverage Ratio1.17
Short Term Coverage Ratio1.26
Capital Expenditure Coverage Ratio2.17
Dividend Paid and Capex Coverage Ratio2.17

Debt and Leverage Ratios

Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 23.03%, highlights its total liabilities relative to assets. With a debt-equity ratio of 0.45, we discern the balance between debt and equity financing. The long-term debt to capitalization, 3.06%, and total debt to capitalization, 30.83%, ratios shed light on its capital structure. An interest coverage of 62.75 indicates its ability to manage interest expenses.

Debt Ratio23.03%
Debt Equity Ratio0.45
Long Term Debt to Capitalization3.06%
Total Debt to Capitalization30.83%
Interest Coverage62.75
Cash Flow to Debt Ratio1.17
Company Equity Multiplier1.94

Per Share Data

Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, 10.15, provides a glimpse into top-line earnings distributed across each share. Net income per share, 1.43, reflects the portion of profit attributed to each share. The book value per share, 4.73, represents the net asset value distributed per share, while the tangible book value per share, 4.69, excludes intangible assets.

Revenue Per Share10.15
Net Income Per Share1.43
Book Value Per Share4.73
Tangible Book Value Per Share4.69
Shareholders Equity Per Share4.73
Interest Debt Per Share0.56
Capex Per Share-1.04

Growth Ratios

Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, 188.33%, indicates top-line expansion, while the gross profit growth, 83.88%, reveals profitability trends. EBIT growth, 463.02%, and operating income growth, 463.02%, offer insights into operational profitability progression. The net income growth, 1118.71%, showcases bottom-line expansion, and the EPS growth, 1100.00%, measures the growth in earnings per share.

Revenue Growth188.33%
Gross Profit Growth83.88%
EBIT Growth463.02%
Operating Income Growth463.02%
Net Income Growth1118.71%
EPS Growth1100.00%
EPS Diluted Growth1100.00%
Weighted Average Shares Growth3.90%
Weighted Average Shares Diluted Growth3.90%
Operating Cash Flow Growth218.02%
Free Cash Flow Growth134.26%
10-Year Revenue Growth per Share6012.12%
10-Year Operating CF Growth per Share194.78%
5-Year Operating CF Growth per Share152.39%
3-Year Operating CF Growth per Share197.69%
10-Year Net Income Growth per Share460.52%
5-Year Net Income Growth per Share129.25%
3-Year Net Income Growth per Share130.43%
10-Year Shareholders Equity Growth per Share-98.62%
5-Year Shareholders Equity Growth per Share203.14%
3-Year Shareholders Equity Growth per Share401.00%
Receivables Growth0.17%
Inventory Growth0.38%
Asset Growth1.05%
Book Value per Share Growth38.12%
Debt Growth-64.25%
R&D Expense Growth11.11%
SGA Expenses Growth160.76%

Other Metrics

Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 293,043,286, captures the company's total value, considering both debt and equity. Income quality, 1.67, assesses the reliability of reported earnings. The sales, general, and administrative to revenue ratio, 0.17, gauges operational efficiency, while the research and development to revenue, 9.22%, highlights investment in innovation. The ratio of intangibles to total assets, 0.40%, indicates the value of non-physical assets, and capex to operating cash flow, -43.08%, measures reinvestment capability.

Enterprise Value293,043,286
Income Quality1.67
Sales General and Administrative to Revenue0.17
Research and Development to Revenue9.22%
Intangibles to Total Assets0.40%
Capex to Operating Cash Flow-43.08%
Capex to Revenue-10.20%
Capex to Depreciation-186.38%
Graham Number12.36
Return on Tangible Assets12.51%
Graham Net Net-2.63
Working Capital7,881,000
Tangible Asset Value75,766,000
Net Current Asset Value-27,484,000
Average Receivables12,471,500
Average Payables18,027,000
Average Inventory8,461,000
Days Sales Outstanding28
Days Payables Outstanding48
Days of Inventory On Hand32

Valuation Ratios

Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 2.33, and the price to book ratio, 2.33, reflect the market's valuation relative to the company's book value. The price to sales ratio, 1.88, provides a perspective on valuation in relation to sales. Ratios like price to free cash flows, 8.27, and price to operating cash flows, 4.47, gauge market valuation against cash flow metrics.

Price Book Value Ratio2.33
Price to Book Ratio2.33
Price to Sales Ratio1.88
Price Cash Flow Ratio4.47
Price Earnings to Growth Ratio0.46
Enterprise Value Multiple4.81
Price Fair Value2.33
Price to Operating Cash Flow Ratio4.47
Price to Free Cash Flows Ratio8.27
Price to Tangible Book Ratio4.44
Enterprise Value to Sales1.79
Enterprise Value Over EBITDA9.45
EV to Operating Cash Flow7.55
Earnings Yield6.83%
Free Cash Flow Yield6.51%
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of Mabion S.A. (MAB.WA) on the WSE in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is 4.771 in 2024.

What is the ticker symbol of Mabion S.A. stock?

The ticker symbol of Mabion S.A. stock is MAB.WA.

What is company IPO date?

IPO date of Mabion S.A. is 2010-08-10.

What is company current share price?

Current share price is 16.000 PLN.

What is stock market cap today?

The market cap of stock today is 258596784.000.

What is PEG ratio in 2024?

The current 0.465 is 0.465 in 2024.

What is the number of employees in 2024?

In 2024 the company has 248.